Skip to main navigation Skip to search Skip to main content

Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer

Translated title of the contribution: Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer
  • C. Martin Silas
  • , D.D. Gagnon
  • , Lucy Zhang
  • , Carsten Bokemeijer
  • , M. van Marwijk Kooy
  • , B.A. van Hout

    Research output: Contribution to journal › Article › Academic › peer-review

    Translated title of the contributionCost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer
    Original languageUndefined/Unknown
    Pages (from-to)1153-1169
    Number of pages16
    JournalPharmacoEconomics
    Volume21
    Issue number16
    Publication statusPublished - 2003

    Cite this